Press release
The Surge Of Lifestyle-Related Health Issues Driving Over-the-Counter (OTC) Drug Market Growth: Strengthening the Growth Trajectory of the Over The Counter (OTC) Drugs Market
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.What Is the Expected CAGR for the Over The Counter (OTC) Drugs Market Through 2025?
In recent times, there has been a consistent increase in the size of the over the counter (OTC) drugs market. It is projected to expand from $158.26 billion in 2024 to $166.04 billion in 2025, registering a compound annual growth rate (CAGR) of 4.9%. The previous growth can be credited to factors such as regulatory transformations, enhanced consumer awareness, healthcare access, demographic changes, and various economic elements.
What's the Projected Size of the Global Over The Counter (OTC) Drugs Market by 2029?
The market size for over the counter (OTC) drugs is projected to experience robust expansion in the forthcoming years. The market is anticipated to soar to approximately $203 billion in 2029, achieving a compound annual growth rate (CAGR) of 5.2%. The projected growth within this timeframe can be credited to an increase in self-treatment practices, wider retail distribution networks, a rising burden of chronic diseases, product innovation, and evolving global health patterns. Notable trends for this forecast period encompass growing consumer interest in natural and herbal remedies, the proliferation of e-commerce channels, the rise of personalized medicine and tailored therapies, a focus on preventative healthcare, and the incorporation of digital health technologies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report
Top Growth Drivers in the Over The Counter (OTC) Drugs Industry: What's Accelerating the Market?
The growth of the over-the-counter (OTC) drugs market is expected to be driven by the rising occurrence of health problems linked to lifestyle choices. These conditions or diseases are mostly influenced by a person's habits, behaviors, and decisions related to diet, exercise, substance abuse, and stress control. Factors such as sedentary lifestyles, unhealthy eating habits, tobacco use, excessive alcohol intake, and increasing stress levels in today's society contribute to the rise in lifestyle-related health issues. OTC drugs come to the fore in managing these health problems as they offer easy-to-access, effective remedies for ordinary conditions associated with contemporary life. For example, the World Health Organization, an intergovernmental organization based in Switzerland, reported in March 2022 that globally, around 1 billion people, including 650 million adults, 340 million adolescents, and 39 million kids, were obese. The instance of obesity is escalating, and it is forecasted that by 2025, 167 million adults and kids will face health problems due to being overweight or obese. Moreover, as per the 2021 data from the Belgium-based International Diabetes Federation, the estimated number of people suffering from diabetes will rise to 643 million by 2030 and 783 million by 2045. Given these factors, the over-the-counter (OTC) drugs market is set to grow, backed by the surging incidence of lifestyle-related health issues.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15630&type=smp
What Trends Will Shape the Over The Counter (OTC) Drugs Market Through 2029 and Beyond?
Leading businesses in the over-the-counter drug industry are creating novel products like over-the-counter sprays to establish a distinct position in the market. Over-the-counter (OTC) sprays are not only easy to use but also deliver therapeutic substances directly to specific body parts. As an example, the biotechnology company from the US, Emergent BioSolutions Inc., launched its OTC NARCAN Naloxone HCl Nasal Spray 4 mg in August 2023. This nasal spray serves as an effective remedy to counteract the effects of opioids, including potent synthetic versions like fentanyl. Due to its user-friendly design, even individuals without medical training can quickly administer it, enabling a swift emergency response.
What Are the Main Segments in the Over The Counter (OTC) Drugs Market?
The over the counter (otc) drugs market covered in this report is segmented -
1) By Product Type: Cough, Cold And Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral And Supplements (VMS), Weight Loss Or Dietary Products, Ophthalmic Products, Sleeping Aids, Other Product Types
2) By Formulation Type: Tablets, Liquids, Ointments, Sprays
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Channels
4) By End-Users: Specialty Clinics, Homecare, Hospitals, Other End Users
Subsegments:
1) By Cough, Cold, And Flu Products: Cough Syrups, Decongestants, Cold And Flu Tablets, Lozenges And Throat Sprays, Nasal Sprays
2) By Analgesics: Pain Relief Tablets (Buprofen, Acetaminophen), Topical Pain Relief (Creams, Gels), Combination Pain Relievers ( Aspirin + Caffeine)
3) By Dermatology Products: Acne Treatments, Skin Moisturizers And Creams, Anti-Aging Products, Sunscreens, Topical Antifungals And Antiseptics
4) By Gastrointestinal Products: Antacids, Laxatives, Digestive Enzymes, Probiotics, Anti-diarrheal Medications
5) By Vitamins, Mineral, And Supplements (Vms): Vitamin Supplements ( Vitamin C, Vitamin D), Mineral Supplements ( Iron, Magnesium), Herbal Supplements, Probiotics And Prebiotics, Omega-3 And Fish Oil
6) By Weight Loss Or Dietary Products: Weight Loss Pills, Meal Replacements, Appetite Suppressants, Fat Burners
7) By Ophthalmic Products: Eye Drops (Lubricating, Antihistamine), Artificial Tears, Contact Lens Solutions, Eye Ointments
8) By Sleeping Aids: Melatonin Supplements, Herbal Sleep Aids ( Valerian Root, Chamomile), Over-The-Counter Sleep Tablets
9) By Other Product Types: Smoking Cessation Products (Nicotine Patches, Gum), Anti-Allergy Medications (Antihistamines), First Aid Supplies (Bandages, Antiseptic Creams), Feminine Hygiene Products (Vaginal Health Supplements)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15630&type=smp
Which Top Companies are Driving Growth in the Over The Counter (OTC) Drugs Market?
Major companies operating in the over the counter (OTC) drugs market are Pfizer Inc., Johnson & Johnson Private Limited, The Procter & Gamble Company, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Ltd., Novo Nordisk A/S, Reckitt Benckiser Group PLC, Viatris Inc., Teva Pharmaceutical Industries Ltd., DAIICHI SANKYO COMPANY LIMITED, Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Perrigo Company plc, Cipla Inc., Dr. Reddy's Laboratories Ltd., Alkem Laboratories Limited, Piramal Enterprises Ltd
Which Regions Will Dominate the Over The Counter (OTC) Drugs Market Through 2029?
North America was the largest region in the over the counter (OTC) drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over the counter (OTC) drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15630
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Surge Of Lifestyle-Related Health Issues Driving Over-the-Counter (OTC) Drug Market Growth: Strengthening the Growth Trajectory of the Over The Counter (OTC) Drugs Market here
News-ID: 4182364 • Views: …
More Releases from The Business Research Company

Inhalation CDMO Industry Outlook 2025-2029: Market Set to Cross $2.84 Billion Mi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Inhalation CDMO Market Size By 2025?
In recent times, the market size of the inhalation CDMO has shown considerable growth. The market, valued at $2.08 billion in 2024, is projected to increase to $2.2 billion in 2025, with a Compound Annual Growth Rate (CAGR) of…

Key Trends Reshaping the Fentanyl Market: Increasing Focus On Product Approvals …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Fentanyl Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, the fentanyl market has experienced robust growth. It is projected to increase from $16.22 billion in 2024 to $17.15 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. The historic growth…

Rising Skin Disease Prevalence Fueling Growth In Complicated Skin And Skin Struc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Complicated Skin And Skin Structure Infections Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of drugs for complex skin and skin structure infections has seen robust growth. The market value will rise from $9.51 billion in 2024 to…

2025 Otic Drugs Market Outlook: Key Indicators Shaping Growth Through 2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Otic Drugs Industry Market Size Be by 2025?
The market size of otic drugs has witnessed substantial growth in the past few years. The market is projected to expand from $1.71 billion in 2024 to $1.82 billion in 2025, at a compound annual growth rate (CAGR)…
More Releases for OTC
Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact…
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain adidas AG officers and…
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE
Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services.
The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology…
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG.
Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,…
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The…
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF).
Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to…